Senior Diabetologist and Founder Director, Diacon Hospital, Bangalore

Persistent hypertension despite treatment can often point towards underlying aldosterone-mediated mechanisms. This expert-led session will explore the role of aldosterone in difficult-to-control hypertension, approaches to identifying patients with aldosterone-driven disease, and evolving strategies for targeted management. The discussion will also examine the emerging role of Aldosterone Synthase Inhibitors (ASI) and their potential to address unmet needs in patients with persistently uncontrolled blood pressure. Featuring insights from Dr. Markus Peter Schlaic and Dr. Prashant Rajput, the session will focus on practical perspectives and the evolving evidence shaping the future of hypertension management.

Aldosterone-Driven Persistently Uncontrolled Hypertension: Exploring the Emerging Role of ASI

Type 2 diabetes care has moved well beyond glucose control alone. Cardiovascular and kidney risk now shape nearly every treatment decision, and most of these patients are first seen and followed up in routine clinical practice. Choosing the right therapy for the right patient is therefore a core skill for every treating physician.

In this case-based session, Dr. Aravind S R and Dr. J J Mukherjee share practical, real-world approaches to T2DM care. The first case takes a cardiocentric approach, covering how to assess cardiovascular risk and select therapy accordingly. The second case focuses on diabetic kidney disease: recognising it early, protecting kidney function, and tailoring glucose-lowering treatment as the disease progresses. The session closes with an open Q&A with both speakers.

Dr. Aravind S R

2

-

-

-

Upcoming Sessions